Johnson & Johnson Vision announced the launch of Tecnis Eyhance IOL, which is designed to extend depth of focus from distance to intermediate vision.
Over the past several decades, India’s eye care system has made tremendous strides towards high quality, accessible solutions to treat growing rates of preventable blindness, with cataracts being one of the leading causes. Cataract accounts for 62.6% of all preventable blindness in India.1 Among several solutions available, patients may opt to undergo a surgical procedure to fit an artificial lens to restore sight after removal of cloudy natural lens.
“This latest innovation from Johnson & Johnson Vision defies conventional thinking about monofocal IOLs by not only delivering high-quality distance vision, but also enhancing vision and better low-light contrast. This will allow patients greater ease in performing important daily tasks which may include focusing on the car navigation system while driving, reading a sign in a store, reading TV subtitles, and walking on uneven surfaces,” Burzin Shahana, Country Manager at Johnson & Johnson Vision – India & South Asia, said in a company news release “The launch of Tecnis Eyhance monofocal IOL in India coincides with this month’s celebration of World Sight Day and its theme of ‘Vision First’ – which resonates perfectly with Johnson & Johnson Vision’s goal of changing the trajectory of eye health and raising the standards of eye care for patients in India and around the world.”
The Tecnis Eyhance IOL offers breakthrough refractive design resulting in continuous increase in power from the periphery to the center of the lens and that will help patients undergoing eye surgery to experience high quality vision at both intermediate and far distances post operation allowing patients to achieve significantly improved intermediate vision, especially in low-illumination settings, compared with a standard aspheric monofocal IOL, along with 20/20 distance vision, according to Johnson & Johnson Vision.
Additionally, data has shown a low incidence of halo, glare or starburst (bright circles of light that surround headlights and other light sources) in Tecnis Eyhance, comparable to what has been reported with the Tecnis one-piece IOL.
In India, Tecnis Eyhance IOL has been approved by the Central Drugs Standard Control Organization (CDSCO).